Skip to main content

Peer Review reports

From: ESCO2’s oncogenic role in human tumors: a pan-cancer analysis and experimental validation

Original Submission
4 Apr 2023 Submitted Original manuscript
13 Apr 2023 Author responded Author comments - Jianqiang Zhu
14 Apr 2023 Author responded Author comments - Jianqiang Zhu
Resubmission - Version 2
13 Apr 2023 Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
30 May 2023 Reviewed Reviewer Report
22 Aug 2023 Reviewed Reviewer Report
6 Sep 2023 Author responded Author comments - Jianqiang Zhu
Resubmission - Version 4
6 Sep 2023 Submitted Manuscript version 4
9 Sep 2023 Author responded Author comments - Jianqiang Zhu
Resubmission - Version 5
9 Sep 2023 Submitted Manuscript version 5
9 Sep 2023 Author responded Author comments - Jianqiang Zhu
Resubmission - Version 6
9 Sep 2023 Submitted Manuscript version 6
20 Sep 2023 Reviewed Reviewer Report
27 Sep 2023 Reviewed Reviewer Report
11 Oct 2023 Author responded Author comments - Jianqiang Zhu
Resubmission - Version 7
11 Oct 2023 Submitted Manuscript version 7
31 Oct 2023 Reviewed Reviewer Report
11 Nov 2023 Author responded Author comments - Jianqiang Zhu
Resubmission - Version 8
11 Nov 2023 Submitted Manuscript version 8
26 Nov 2023 Author responded Author comments - Jianqiang Zhu
Resubmission - Version 9
26 Nov 2023 Submitted Manuscript version 9
24 Dec 2023 Reviewed Reviewer Report
Resubmission - Version 10
Submitted Manuscript version 10
Publishing
1 Apr 2024 Editorially accepted
11 Apr 2024 Article published 10.1186/s12885-024-12213-w

You can find further information about peer review here.

Back to article page